Go offline with the Player FM app!
π« Foxglove, Frailty, and HFrEF β Digitoxin in Advanced Heart Failure
Manage episode 503362835 series 2740117
π¨ New RCT Alert from the NEJM!
Can an old π make a comeback in modern π failure care?
π The DIGIT-HF trial showed that digitoxin, a cardiac glycoside with hepatic clearance, reduced the combined endpoint of all-cause death or HF hospitalization in HFrEF patients on contemporary guideline-directed therapy β including ARNI, beta-blockers, MRAs & SGLT2i.
π©Ί HR = 0.82; p = 0.03 π
π©ββοΈ Safe in CKD, consistent benefit in women.
β οΈ Serious AEs slightly higher (4.7% vs 2.8%)
π₯ NNT = 22.
π‘Is it time to reconsider digitoxin in advanced HFrEF?
#CardioTwitter #HFrEF #HeartFailure #Digitoxin #NEJM #Cardiology #SGLT2i #GuidelineTherapy
673 episodes
Manage episode 503362835 series 2740117
π¨ New RCT Alert from the NEJM!
Can an old π make a comeback in modern π failure care?
π The DIGIT-HF trial showed that digitoxin, a cardiac glycoside with hepatic clearance, reduced the combined endpoint of all-cause death or HF hospitalization in HFrEF patients on contemporary guideline-directed therapy β including ARNI, beta-blockers, MRAs & SGLT2i.
π©Ί HR = 0.82; p = 0.03 π
π©ββοΈ Safe in CKD, consistent benefit in women.
β οΈ Serious AEs slightly higher (4.7% vs 2.8%)
π₯ NNT = 22.
π‘Is it time to reconsider digitoxin in advanced HFrEF?
#CardioTwitter #HFrEF #HeartFailure #Digitoxin #NEJM #Cardiology #SGLT2i #GuidelineTherapy
673 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.